REQUEST A DEMO
Total
USD $0.00
Search more companies

Apollo Capital ASI S.A. (Poland)

Main Activities: Securities and Commodity Contracts Intermediation and Brokerage | Other Investment Pools and Funds
Full name: Apollo Capital Alternatywna Spolka Inwestycyjna S.A. Profile Updated: March 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Apollo Capital Alternatywna Spółka Inwestycyjna S.A. and Bio-Med SA Investors) is a leading entity in the investment activities of market entities both public and private funds on the basis of their own. Company's main business is to attract investment capital and the realization of the accumulated funds in selected companies, financing their development by further capital injections, periodic lending of funds.

Headquarters
ul. Grzegorzecka 67D lok. 26
Krakow; Malopolskie; Postal Code: 31-559

Contact Details: Purchase the Apollo Capital ASI S.A. report to view the information.

Website: http://www.apollocapitalasi.com

Basic Information
Total Employees:
Purchase the Apollo Capital ASI S.A. report to view the information.
Outstanding Shares:
Purchase the Apollo Capital ASI S.A. report to view the information.
Registered Capital:
Purchase the Apollo Capital ASI S.A. report to view the information.
Financial Auditors:
Purchase the Apollo Capital ASI S.A. report to view the information.
Incorporation Date:
March 12, 2010
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Ownership Details
Purchase this report to view the information.
27.86%
Purchase this report to view the information.
25.92%
Purchase this report to view the information.
9.11%
Purchase this report to view the information.
9.11%
Purchase this report to view the information.
4.39%
Subsidiaries
Msi Bioscience Sp. z o.o.
100%
Ameds Pharma Sp. z o.o.
40%
Histogen Europe Sp. z o.o.
25%
Company Performance
Financial values in the chart are available after Apollo Capital ASI S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
-66.25%
Operating profit (EBIT)
-13.33%
Net Profit (Loss) for the Period
92.75%
Total assets
32.65%
Total equity
-0.78%
Return on Equity (ROE)
-116.56%
Debt to Equity Ratio
-0.68%
Quick Ratio
0%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?